Physician profile
Aimee Weber
NPI 1942860416
$4,374.75
in general payments reported to CMS, 2019-2025
11 companies · $2,558 in 2025
The $2,558 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $185 · 2023: $1,614 · 2024: $17.00 · 2025: $2,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,280 · Travel and Lodging: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.32 |
| Travel and Lodging | $1,909.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,700.93 | 2023-2025 | Mazor X System, Cd Horizon Spinal System, Strata |
| Icotec Medical INC. | $1,027.64 | 2023 | Icotec Blackarmor Spine System |
| Arteriocyte Medical Systems, INC. | $570.20 | 2023-2025 | Magellan |
| Si-Bone, INC. | $327.81 | 2022-2023 | |
| Globus Medical, INC. | $243.77 | 2025 | Excelsius Gps |
| Stryker Corporation | $218.24 | 2024-2025 | 1788, N/A, Adherus Autospray Dural Sealant |
| Depuy Synthes Sales INC. | $193.33 | 2023-2025 | Viper, N/A, Cerepak Uniform |
| Aesculap, INC. | $38.48 | 2025 | M.Blue |
| Biocomposites INC | $20.58 | 2025 | Stimulan |
| Medical Device Business Services, INC. | $20.45 | 2025 | Teligen |
| Puma Biotechnology, INC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.